TIRZEPATIDE

Tirzepatide (GLP-2) is a synthetic dual incretin peptide targeting both GLP-1 and GIP receptor pathways. Work with it centers on glucose-dependent insulinotropic signaling and metabolic regulation.

Compound

Tirzepatide, dual GIP / GLP-1 receptor agonist

CAS number

2023788-19-2

Molecular weight

4813.5 g/mol

Form

Lyophilized powder in a sealed glass vial

Strength

10mg / 30mg per vial

Purity

>99% (brand-wide standard), measured 99.46% on the current lot

Testing

HPLC purity, mass spectrometry identity, bacterial endotoxin (pass), run by Horizon Analytical

Documentation

Lot 7523062, tested Aug 30, 2026 certificate of analysis

Storage

Lyophilized: sealed at -20°C, protected from light and moisture.

Origin

Vialed, finished, tested and shipped in the USA

Intended use

Research use only. Not for human or veterinary use.

Pricing and ordering are available to signed-in research accounts.